Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We also found that CDKN1A expression in mutant p53 colon cancer tissue was significant decreased when compared with p53 wild type colon cancer tissue, while Wnt ligand Wnt5a exhibited the highest level in p53 mutant colon cancer tissue.
|
30833076 |
2019 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Increased nuclear localization of p21(WAF1/CIP1) in SPRY2 downregulated colon cancer cells may explain the inhibition of cell proliferation in colon cancer cells.
|
26293890 |
2016 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Ectopic expression of miR-139-5p in colon cancer cell lines significantly suppressed cell growth as evidenced by cell viability assay (P < 0.001) and colony formation assay (P < 0.01) and in xenograft tumor growth in nude mice (P < 0.01). miR-139-5p induced apoptosis (P < 0.01), concomitantly with up-regulation of key apoptosis genes including cleaved caspase-8, caspase-3, caspase-7 and PARP. miR-139-5p also caused cell cycle arrest in G0/G1 phase (P < 0.01), with upregulation of key G0/G1 phase regulators p21Cip1/Waf1 and p27Kip1.
|
24885920 |
2014 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
To our knowledge, this is the first report showing that cladosporol A inhibits colon cancer cell proliferation by modulating p21(waf1/cip1) expression.
|
22025467 |
2013 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells.
|
22814028 |
2012 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here, we examined the roles of p53 and p21(Cip1/WAF1) in senescence development induced by CKII inhibition using wild-type, isogenic p53-/- and isogenic p21-/- HCT116 human colon cancer cell lines.
|
19855935 |
2009 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sulindac has been reported to be effective in suppressing tumor growth through the induction of p21WAF1/cip1 in human, animal models of colon cancer and colon cancer cells.
|
18291362 |
2008 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In addition, CLP-mediated cell cycle arrest was reduced by the knockout of the p21(WAF1/CIP1) gene in human colon cancer HCT116 cells, suggesting that the cell cycle arrest by CLP was at least partially mediated through the induction of p21(WAF1/CIP1) expression.
|
17786325 |
2007 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Thus, p68/p72 may contribute to colon cancer formation by directly up-regulating proto-oncogenes and indirectly by down-regulating the growth suppressor p21(WAF1/CIP1).
|
17699760 |
2007 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We investigated the effect of a novel histone deacetylase inhibitor, A-423378.0, on the colon carcinoma cell line HCT116 and genetically modified derivatives lacking either p21(cip1/waf1) or p53.
|
17982666 |
2007 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
SC-560 combined with other therapy that can block p21 CIP1 expression or function may contribute to the effective treatment of colon cancer.
|
16819292 |
2006 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Artepillin C appears to prevent colon cancer through the induction of cell-cycle arrest by stimulating the expression of Cip1/p21 and to be a useful chemopreventing factor in colon carcinogenesis.
|
16224795 |
2005 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Cells of a colon cancer cell line DLD-1 were transfected with p21(WAF1) expression vector controlled by a tetracycline-repressable promoter and transfectants were cloned (Dp21-1). p21(WAF1) expression induced by removal of tetracycline from culture media repressed cell proliferation and resulted in altered cell shape, suggesting induction of differentiation.
|
12824923 |
2003 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
|
12810668 |
2003 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we found that treatment of the cultured human colon cancer cell line COLO-205 with a PKC agonist, 12-O-tetradecanoylphorbol-13-acetate (TPA), resulted in cell-cycle arrest at the G(0)/G(1) phase, decrease in cell number, PKCgamma isoform translocation, and upregulation of p21(Cip1) protein.
|
12203364 |
2002 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Studies were performed in human colon cancer HCT-116 cells and murine embryonic fibroblasts (MEF) with intact versus disrupted p21 genes.
|
9174048 |
1997 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We examined the effect of butyrate on the expression of WAF1/Cip1, a potent inhibitor of cyclin-dependent kinases, and its relation to growth arrest in a p53-mutated human colon cancer cell line WiDr.
|
9268365 |
1997 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In contrast, a mutant p53 bearing human colon cancer cell line, sw480, lacked spontaneous apoptosis, and upon irradiation neither induction of apoptosis nor increase expression of p53 and WAF-1 were seen.
|
9206101 |
1996 |